Gregory Hill
@Essex Woodlands Management, Inc.
Latest period2024 - Q3ReportedManaged Assets$350.395MTotal holdings7
Assets growth rate14.25%Assets growth rate (2-Q avg)1.6%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Essex Woodlands Management, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 7 positions.
Assets under management
The assets under management (AUM) of Essex Woodlands Management, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 350.395M in assets, with a quarterly growth rate of 14.25% and a 2-quarter average growth rate of 1.6%. The portfolio is managed by Gregory Hill, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MDXGMimedx Group, Inc.
| 47.56% | $166.634M 28.195M shares@ $5.92 avg price | |
BVSBioventus
| 44.41% | $155.605M 13.021M shares@ $11.96 avg price | |
EYPTEyepoint Pharmaceuticals Inc
| 3.54% | $12.397M 1.552M shares@ $8.0 avg price | |
TELATela Bio, Inc.
| 2.97% | $10.4M 4.111M shares@ $2.54 avg price | |
RVNCRevance Therapeutics Inc
| 0.68% | $2.372M 457,085 shares@ $5.19 avg price | |
MNOVMedicinova Inc
| 0.67% | $2.322M 1.106M shares@ $2.1 avg price | |
VEROVenus Concept, Inc.
| 0.19% | $664,842 1.089M shares@ $0.62 avg price |